FGF21 and obesity due to melanocortin 4 receptor deficiency: Several studies have demonstrated therapeutic benefits of FGF21 for obesity-related metabolic disorders, including the reduction in adiposity and improvement in insulin resistance, NAFLD, among others (155, 156).